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Editorial
Screening and surveillance 
in respiratory medicine
We are already a couple of months into 2020 and 
I hope you had a good start to the new year. I wish 
you, our readers, reviewers, authors and editors, 
happiness, success and health in this new decade.
In 2019, Breathe continued to grow its 
readership, increasing online views by 60% 
compared to the previous year. Readers in the USA 
and India constitute some of our largest reader 
groups, illustrating the worldwide reach of the 
journal. Online content of Breathe is accessed via 
mobile devices in 38% of all page views, aligned 
with how web content is accessed in general. 
The March 2019 issue entitled “Too much or too 
little medicine? Overdiagnosis, underdiagnosis, 
overtreatment and undertreatment in respiratory 
diseases” proved particularly popular. Two articles in 
that issue, one on over- and misdiagnosis of COPD 
[1] and the other one on over- and under-diagnosis 
of asthma [2], were among the top three articles 
that received the most attention last year (based on 
Altmetric scores). Another favourite with our readers 
was the article “Introduction of the harmonised 
respiratory physiotherapy curriculum” [3].
Most of the spontaneous submissions that 
Breathe receives are interactive case reports but we 
also welcome spontaneous submissions in most 
other categories; for details refer to the Breathe 
Instructions for authors (https://breathe.ersjournals.
com/authors/instructions). Each issue of Breathe 
will continue to be dedicated to a specific topic; 
reviews aligned with the issue topics are currently all 
commissioned. However, we hope to see spontaneous 
submissions of thematic reviews in the future. Due 
to this, the topics of forthcoming issues are listed 
on the Breathe website (https://breathe.ersjournals.
com/forthcoming). The topics for 2020 are: Rare and 
orphan lung diseases (submission closed); Models 
of care in respiratory medicine (submission deadline 
April 2020); and Systemic diseases and the lung 
(submission deadline July 2020).
We plan to introduce a new article type called 
“Ask the expert” in which a topic expert will 
succinctly answer and discuss a specific question 
in the field of respiratory medicine. Please send any 
questions you may have to the Breathe editorial 
office (breathe@ersnet.org).
From this year, Breathe will be an online only 
publication. The interest in paper copies has 
been dwindling over recent years, and giving up 
paper copies altogether will contribute to the 
environmental sustainability of our publication.
The current issue focuses on screening (and 
surveillance) in respiratory medicine. The topic 
is timely in light of the current discussions about 
the implementation of lung cancer screening 
programmes in Europe and beyond, and the 
re-emergence of occupational dust lung diseases 
such as coal workers’ pneumoconiosis and silicosis 
in the USA and Australia [4].
I would like to thank all contributors to this issue, 
as well as the hard-working members of the editorial 
office and leave you with the following quote:
“Do as much as possible for the patient, and as 
little as possible to the patient.”
Dr Bernard Lown
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